BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17875939)

  • 1. Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene.
    Igarashi M; Yogiashi Y; Mihara M; Takada I; Kitagawa H; Kato S
    Mol Cell Biol; 2007 Nov; 27(22):7947-54. PubMed ID: 17875939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor.
    Rokutanda N; Iwasaki T; Odawara H; Nagaoka R; Miyazaki W; Takeshita A; Koibuchi Y; Horiguchi J; Shimokawa N; Iino Y; Morishita Y; Koibuchi N
    Endocrine; 2008 Jun; 33(3):305-16. PubMed ID: 19011999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR.
    Tabb MM; Sun A; Zhou C; Grün F; Errandi J; Romero K; Pham H; Inoue S; Mallick S; Lin M; Forman BM; Blumberg B
    J Biol Chem; 2003 Nov; 278(45):43919-27. PubMed ID: 12920130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion.
    Masuyama H; Suwaki N; Tateishi Y; Nakatsukasa H; Segawa T; Hiramatsu Y
    Mol Endocrinol; 2005 May; 19(5):1170-80. PubMed ID: 15650019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid and xenobiotic receptor mediates a novel vitamin K2 signaling pathway in osteoblastic cells.
    Horie-Inoue K; Inoue S
    J Bone Miner Metab; 2008; 26(1):9-12. PubMed ID: 18095058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells.
    Ichikawa T; Horie-Inoue K; Ikeda K; Blumberg B; Inoue S
    J Mol Endocrinol; 2007 Oct; 39(4):239-47. PubMed ID: 17909264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation.
    Konno Y; Kodama S; Moore R; Kamiya N; Negishi M
    Mol Pharmacol; 2009 Feb; 75(2):265-71. PubMed ID: 18981260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells.
    Ichikawa T; Horie-Inoue K; Ikeda K; Blumberg B; Inoue S
    J Biol Chem; 2006 Jun; 281(25):16927-16934. PubMed ID: 16606623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures.
    Takeuchi Y; Suzawa M; Fukumoto S; Fujita T
    Bone; 2000 Dec; 27(6):769-76. PubMed ID: 11113387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PROX1 suppresses vitamin K-induced transcriptional activity of Steroid and Xenobiotic Receptor.
    Azuma K; Urano T; Watabe T; Ouchi Y; Inoue S
    Genes Cells; 2011 Nov; 16(11):1063-70. PubMed ID: 22023334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and interplay of sequence specific DNA binding proteins involved in regulation of human Pregnane and Xenobiotic Receptor gene.
    Saradhi M; Kumari S; Rana M; Mukhopadhyay G; Tyagi RK
    Exp Cell Res; 2015 Dec; 339(2):187-96. PubMed ID: 26586566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene.
    Hassan MQ; Javed A; Morasso MI; Karlin J; Montecino M; van Wijnen AJ; Stein GS; Stein JL; Lian JB
    Mol Cell Biol; 2004 Oct; 24(20):9248-61. PubMed ID: 15456894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycyclic aromatic hydrocarbons stimulate human CYP3A4 promoter activity via PXR.
    Luckert C; Ehlers A; Buhrke T; Seidel A; Lampen A; Hessel S
    Toxicol Lett; 2013 Oct; 222(2):180-8. PubMed ID: 23845848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pregnane X receptor binds to response elements in a genomic context-dependent manner, and PXR activator rifampicin selectively alters the binding among target genes.
    Song X; Xie M; Zhang H; Li Y; Sachdeva K; Yan B
    Drug Metab Dispos; 2004 Jan; 32(1):35-42. PubMed ID: 14709618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function analysis of Msx2-mediated transcriptional suppression.
    Newberry EP; Latifi T; Battaile JT; Towler DA
    Biochemistry; 1997 Aug; 36(34):10451-62. PubMed ID: 9265625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
    Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
    Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnane X receptor (PXR) represses osteoblast differentiation through repression of the Hedgehog signaling pathway.
    Saeki N; Itoh Y; Kanai R; Itoh S; Inububishi T; Akiyama S; Inui-Yamamoto C; Abe M
    Exp Cell Res; 2022 Jul; 416(1):113156. PubMed ID: 35421365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mycoestrogen zearalenone induces CYP3A through activation of the pregnane X receptor.
    Ding X; Lichti K; Staudinger JL
    Toxicol Sci; 2006 Jun; 91(2):448-55. PubMed ID: 16547076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1alpha.
    Itoh M; Nakajima M; Higashi E; Yoshida R; Nagata K; Yamazoe Y; Yokoi T
    J Pharmacol Exp Ther; 2006 Nov; 319(2):693-702. PubMed ID: 16857725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.